Octave Specialty Group, Inc.
Octave Specialty Group, Inc. functions as a financial services holding company, organizing its operations into two distinct divisions. Its Specialty Property and Casualty Insurance segment delivers specialized program insurance, primarily focusing on coverage for commercial and personal liability exposures. The second…
1D
+1.3%
1W
+0.9%
1M
-1.5%
6M
-3.9%
YTD
-40.1%
1Y
-41.8%
2Y
-61.0%
5Y
-68.7%
10Y
-75.8%
Next earnings date
09/11/2026 (in 23 days)
Volatility around earnings
~116% stronger price swings than usual
PRICE TARGET LOW
US$10.00
CONSENSUS
US$14.00
MEDIAN
US$14.00
PRICE TARGET HIGH
US$18.00
0
STRONG BUY
5
BUY
6
HOLD
2
SELL
0
STRONG SELL
13
TOTAL · Hold
As of: 12/11/2025
P/E
-1.28
P/B
0.3
EV/EBITDA
-15.95
RETURN ON EQUITY
-2.1%
NET MARGIN
-17.4%
DEBT/EQUITY
0.22
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
94.2%
FLOAT SHARES
42,448,862
AVG. DAILY VOLUME (30D)
506,781
LeBlanc Claude
Trick David
Smith R Sharon
Smith R Sharon
LeBlanc Claude
Octave Specialty Group, Inc. is a company in the Financial Services sector, Insurance - Specialty industry, headquartered in United States.
The CEO is Claude LeBlanc, the company employs around 483 people.
The IPO was on 01/05/2013; the stock trades on NYSE under the ticker OSG.
13 analysts rate the stock, the consensus is Hold (as of 12/11/2025).
The average price target is US$14.00, ranging from US$10.00 to US$18.00, with a median of US$14.00.
This is an external assessment, not a statement by Market Jury.
The next earnings date is 09/11/2026.
Around past earnings, price swings were roughly 116% stronger than usual.
No, Octave Specialty Group currently does not pay a dividend.
Comparable stocks include Radian Group, Investors Title Company, Beazley, Essent Group, Berkshire Hathaway, Berkshire Hathaway, JPMorgan Chase & and Visa.
Clicking "Analyze stock" lets five strategies assess Octave Specialty Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.